|
Daily Medical Update
Carpal Tunnel Syndrome
Saturday, May 16, 2026
|
🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the
last 12 months.
|
Lancet (London, England) (2025) - Randomized Controlled Trial
Key Findings
- At 18 months, recovery occurred in 61% of the surgery-first group versus 45% of the injection-first group (relative risk 1.36; 95% CI 1.19-1.56).
- Adverse event rates were similar at 86% after surgery-first and 85% after injection-first treatment, with one hospitalization in the surgery arm and no treatment-related deaths.
📋 Practice Implication: For patients with persistent CTS confirmed on testing, offering decompression earlier is more likely to produce durable recovery than beginning with corticosteroid injection alone.
|
NEJM Evidence (2026) - Randomized Controlled Trial
Key Findings
- The 12-week symptom score change did not differ significantly between rigid splinting and placebo bandage (adjusted mean difference 0.08; 95% CI -0.15 to 0.31; P=0.478).
- By 1 year, surgery rates were similar at 57.1% with splinting and 51.4% with placebo bandage, and no serious adverse events were reported.
📋 Practice Implication: Rigid wrist splinting should not be presented as a strongly effective standalone therapy for untreated idiopathic CTS when placebo-level benefit is the likely outcome.
|
Hand (New York, N.Y.) (2024) - Meta-Analysis
Key Findings
- Pooled sensitivity was 86.4% for neuromuscular ultrasound and 91.6% for electrodiagnostic studies, with specificity 79.3% and 81.9%, respectively.
- Overall diagnostic accuracy was not significantly different, although electrodiagnostic studies had stronger likelihood ratios and a higher diagnostic odds ratio (49 vs 24).
📋 Practice Implication: Ultrasound is a reasonable confirmatory test when access or tolerability limits electrodiagnostics, but EDX still offers the more dependable rule-in and rule-out performance.
|
Pain Medicine (Malden, Mass.) (2026) - Randomized Controlled Trial
Key Findings
- Compared with sham treatment, the intervention produced significantly greater improvements across follow-up visits in pain intensity, disability, sensory thresholds, and neural mobility, with effect sizes from 0.64 to 2.09.
- Benefits in pain and function were maintained through 6 months, while grip and pinch strength did not improve significantly.
📋 Practice Implication: For mild to moderate CTS patients seeking nonsurgical care, ultrasound-guided percutaneous electrolysis with nerve stimulation may be an option when pain and functional limitation are the main treatment targets.
|
Medicine (2025) - Meta-Analysis
Key Findings
- Across 17 studies and 996 patients, ultrasound-guided needle-knife therapy improved pain, wrist function, sensory conduction velocity, distal motor latency, and ultrasound measures versus control treatment (all P<.05).
- Needle-knife therapy increased clinical effectiveness and increased cure rates versus control treatment, with pooled effect estimates favoring intervention for both outcomes.
📋 Practice Implication: This technique may be considered as an adjunctive conservative intervention where trained operators are available, especially when symptom relief and electrophysiologic improvement are both desired.
|
|
💡
Summary
Recent carpal tunnel syndrome evidence favors surgery-first management over injection-first care for longer-term recovery, while a placebo-controlled trial found rigid wrist splinting did not meaningfully improve symptoms or reduce later surgery. Diagnostic meta-analysis suggests neuromuscular ultrasound approaches electrodiagnostic performance but remains slightly less accurate, and several ultrasound-guided minimally invasive interventions improved pain, function, and nerve measures in selected patients.
|
|